11736 Federal Register / Vol. 74, No. 52 / Thursday, March 19, 2009 / Notices 

Drugs program. Type of Respondent: 

Participants will include high school 

students enrolled in the tenth and 

eleventh grade. Estimated Total Annual 

Number of Respondents: 360. Estimated 

Number of Responses per Respondent: 

4. Average Burden Hours per Response: 

One high school period lasting 50 

minutes. Estimated Total Annual 

Burden Hours Requested: 1199.95. 

There are no Capital Costs to report. 

There are no Operating or Maintenance 

Costs to report. The estimated 

annualized burden is summarized 

below. 

Type of respondents Number of 

respondents 

Frequency of 

response 

Average burden 

hours per 

response 

Estimated total 

burden hours 

requested 

Participants—High School Students ................................................ 360 4 .8333 1199.95 

Total .......................................................................................... 360 4 .8333 1199.95 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(2) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (3) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974, Attention: Desk 

Officer for NIH. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact: Dr. 

Cathrine Sasek, Coordinator, Science 

Education Program, Office of Science 

Policy and Communications, National 

Institute on Drug Abuse, 6001 Executive 

Blvd, Room 5237, Bethesda, MD 20892, 

or call non-toll-free number (301) 443– 

6071; fax (301) 443–6277; or by e-mail 

to csasek@nida.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: March 12, 2009. 

Mary Affeldt, 

Associate Director for Management, National 

Institute on Drug Abuse. 

[FR Doc. E9–6037 Filed 3–18–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request; Survey of NHLBI 

Constituents’ Health Information 

Needs and Preferred Formats 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Heart, Lung and Blood 

Institute (NHLBI), the National 

Institutes of Health (NIH) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection: Title: Survey of 

NHLBI Constituents’ Health Information 

Needs and Preferred Formats. Type of 

Information Collection Request: NEW. 

Need and Use of Information Collection: 

The purpose of this survey is to obtain 

information from NHLBI constituents 

(health professionals, patients and their 

families, and the general public) for the 

purpose of evaluating their health 

information and education needs and 

format preferences. The Consumer 

Services Team (CST) will use the data 

collected in this survey to create a 3- 

year Strategic Plan. The findings from 

the survey, described in the Strategic 

Plan, will be used to develop new 

health information materials for NHLBI 

constituents and to revise materials 

currently in the Institute’s portfolio. 

Frequency of Response: Once every 3 

years. Affected Public: Individuals. Type 

of Respondents: Individuals who have 

been consumers of NHLBI information 

within the past 3 years. The annual 

reporting burden is as follows: 

Estimated Number of Respondents: 

2,450; Estimated Number of Responses 

per Respondent: 1; Average Burden 

Hours Per Response: 0.2; and Estimated 

Total Annual Burden Hours Requested: 

162. The annualized cost to respondents 

is estimated at: $3,518.62. There are no 

Capital Costs, Operating Costs, and/or 

Maintenance Costs to report. 

Type of respondents 

Estimated 

number of 

respondents 

Estimated 

number of 

responses per 

respondent 

Average burden 

hours per 

response 

Estimated total 

annual burden 

hours requested 

General Public ................................................................................. 1,075 0.33 0.2 71 

Private Companies .......................................................................... 332 0.33 0.2 22 

Public Sector Groups ....................................................................... 332 0.33 0.2 22 

Health Professionals ........................................................................ 711 0.33 0.2 47 

Totals ........................................................................................ 2,450 ............................ ............................ 162 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 74, No. 52 / Thursday, March 19, 2009 / Notices 11737 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION: To request 

more information on the proposed 

project or to obtain a copy of the data 

collection plans and instruments, 

contact Dr. Ann M. Taubenheim, 

Principal Investigator, National Heart, 

Lung, and Blood Institute, Office of 

Communications and Legislative 

Activities, NIH, 31 Center Drive, 

Building 31, Room 4A10, Bethesda, MD 

21045, or call non-toll-free number 301– 

496–4236 or e-mail your request, 

including your address, to 

taubenha@nhlbi.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: March 11, 2009. 

Ann M. Taubenheim, 

Principal Investigator, NHLBI. 

[FR Doc. E9–6052 Filed 3–18–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel. CB IRG 

Member SEP. 

Date: March 24, 2009. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Jonathan Arias, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5170, 

MSC 7840, Bethesda, MD 20892. 301–435– 

2406. ariasj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 13, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–6028 Filed 3–18–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Cancer 

Therapeutics. 

Date: April 2, 2009. 

Time: 9 a.m. to 10:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call) 

Contact Person: Syed M. Quadri, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6210, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1211, quadris@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Innovative 

Application of Nanotechnology to Heart, 

Lung, Blood, and Sleep Disorders. 

Date: April 6–7, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Noni Byrnes, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5130, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1023, byrnesn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Nephrology 

and Urology Clinical and Small Business. 

Date: April 6–7, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Ryan G. Morris, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4205, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1501, morrisr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Molecular 

Mechanisms of Aging and 

Neurodegeneration. 

Date: April 6, 2009. 

Time: 1:15 p.m. to 4:45 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4512, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1257, baizerl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Psychopharmacology. 

Date: April 8–9, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Christine L. Melchior, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5176, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1713, melchioc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts in Molecular Neuroscience. 

Date: April 8, 2009. 

Time: 2 p.m. to 5 p.m. 


sroberts on PROD1PC70 with NOTICES